1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Visualization Instruments for MIS Market
4. Market Overview
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Visualization Instruments for MIS Market Value Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Technological Advancements
5.2. Key Industry Events
5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Visualization Instruments for MIS Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Visualization Systems
6.3.1.1. 2D Systems
6.3.1.2. 3D Systems
6.3.2. Consumables & Accessories
6.4. Market Attractiveness Analysis, by Product Type
7. Global Visualization Instruments for MIS Market Analysis and Forecast, by MIS Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by MIS Type, 2017–2031
7.3.1. Endoscopy
7.3.1.1. Arthroscopy
7.3.1.2. Laparoscopy
7.3.1.3. Obstetrics & Gynecology Endoscopy
7.3.1.4. Urologic Endoscopy
7.3.1.5. Bronchoscopy
7.3.1.6. Gastroscopy
7.3.1.7. Others
7.3.2. Robotic Surgery
7.4. Market Attractiveness Analysis, by MIS Type
8. Global Visualization Instruments for MIS Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Ambulatory Surgery Centers
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Visualization Instruments for MIS Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Visualization Instruments for MIS Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Visualization Systems
10.2.1.1. 2D Systems
10.2.1.2. 3D Systems
10.2.2. Consumables & Accessories
10.3. Market Value Forecast, by MIS Type, 2017–2031
10.3.1. Endoscopy
10.3.1.1. Arthroscopy
10.3.1.2. Laparoscopy
10.3.1.3. Obstetrics & Gynecology Endoscopy
10.3.1.4. Urologic Endoscopy
10.3.1.5. Bronchoscopy
10.3.1.6. Gastroscopy
10.3.1.7. Others
10.3.2. Robotic Surgery
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Ambulatory Surgery Centers
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By MIS Type
10.6.3. By End-user
10.6.4. By Country
11. Europe Visualization Instruments for MIS Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Visualization Systems
11.2.1.1. 2D Systems
11.2.1.2. 3D Systems
11.2.2. Consumables & Accessories
11.3. Market Value Forecast, by MIS Type, 2017–2031
11.3.1. Endoscopy
11.3.1.1. Arthroscopy
11.3.1.2. Laparoscopy
11.3.1.3. Obstetrics & Gynecology Endoscopy
11.3.1.4. Urologic Endoscopy
11.3.1.5. Bronchoscopy
11.3.1.6. Gastroscopy
11.3.1.7. Others
11.3.2. Robotic Surgery
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Ambulatory Surgery Centers
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By MIS Type
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Visualization Instruments for MIS Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Visualization Systems
12.2.1.1. 2D Systems
12.2.1.2. 3D Systems
12.2.2. Consumables & Accessories
12.3. Market Value Forecast, by MIS Type, 2017–2031
12.3.1. Endoscopy
12.3.1.1. Arthroscopy
12.3.1.2. Laparoscopy
12.3.1.3. Obstetrics & Gynecology Endoscopy
12.3.1.4. Urologic Endoscopy
12.3.1.5. Bronchoscopy
12.3.1.6. Gastroscopy
12.3.1.7. Others
12.3.2. Robotic Surgery
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Ambulatory Surgery Centers
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By MIS Type
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Visualization Instruments for MIS Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Visualization Systems
13.2.1.1. 2D Systems
13.2.1.2. 3D Systems
13.2.2. Consumables & Accessories
13.3. Market Value Forecast, by MIS Type, 2017–2031
13.3.1. Endoscopy
13.3.1.1. Arthroscopy
13.3.1.2. Laparoscopy
13.3.1.3. Obstetrics & Gynecology Endoscopy
13.3.1.4. Urologic Endoscopy
13.3.1.5. Bronchoscopy
13.3.1.6. Gastroscopy
13.3.1.7. Others
13.3.2. Robotic Surgery
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Ambulatory Surgery Centers
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By MIS Type
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Visualization Instruments for MIS Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Visualization Systems
14.2.1.1. 2D Systems
14.2.1.2. 3D Systems
14.2.2. Consumables & Accessories
14.3. Market Value Forecast, by MIS Type, 2017–2031
14.3.1. Endoscopy
14.3.1.1. Arthroscopy
14.3.1.2. Laparoscopy
14.3.1.3. Obstetrics & Gynecology Endoscopy
14.3.1.4. Urologic Endoscopy
14.3.1.5. Bronchoscopy
14.3.1.6. Gastroscopy
14.3.1.7. Others
14.3.2. Robotic Surgery
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Ambulatory Surgery Centers
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By MIS Type
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Arthrex GmbH
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. B. Braun Melsungen AG
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. CONMED Corporation
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Medtronic plc
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Millennium Surgical Corp
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.5.5. Strategic Overview
15.3.6. Richard Wolf GmbH
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Lazurite Holdings LLC
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Smith & Nephew plc
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Stryker Corporation
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Product Portfolio
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Olympus Corporation
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer